GWP
EDIT icon

Gen-Wealth Partners’s Editas Medicine EDIT Stock Holding History

Gen-Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172 Hold
53
– – ﹤0.01% 709
2026
Q1 		$131 Hold
53
– – ﹤0.01% 717
2025
Q4 		$109 Hold
53
– – ﹤0.01% 684
2025
Q3 		$184 Hold
53
– – ﹤0.01% 674
2025
Q2 		$117 Hold
53
– – ﹤0.01% 637
2025
Q1 		$61 Hold
53
– – ﹤0.01% 615
2024
Q4 		$67 Hold
53
– – ﹤0.01% 644
2024
Q3 		$160 Hold
53
– – ﹤0.01% 651
2024
Q2 		$248 Hold
53
– – ﹤0.01% 630
2024
Q1 		$393 Buy
+53
New +$440 ﹤0.01% 609

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Gen-Wealth Partners's EDIT Position: Q2 2026 in Review

Gen-Wealth Partners held its Editas Medicine (EDIT) position steady in Q2 2026 at 53 shares worth $172. The position accounts for ﹤0.01% of the portfolio, ranked #709.

Gen-Wealth Partners first reported a position in EDIT in Q1 2024 and has held it in 10 quarters since. The position peaked at $393 in Q1 2024. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Gen-Wealth Partners held 53 shares of Editas Medicine worth $172 as of Q2 2026.
  • Gen-Wealth Partners left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #709 holding.
  • Gen-Wealth Partners first reported a position in Editas Medicine in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Editas Medicine position peaked at $393 in Q1 2024.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.